Egfr-Aa 120

Lab Reagents

Egfr Assay Laboratories manufactures the egfr-aa 120 reagents distributed by Genprice. The Egfr-Aa 120 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact egfr assay. Other Egfr-Aa products are available in stock. Specificity: Egfr-Aa Category: 120

Test Assays information

Mouse Epidermal Growth Factor Receptor (EGFR) ELISA Kit

RDR-EGFR-Mu-96Tests 96 Tests
EUR 618

Rat Epidermal Growth Factor Receptor (EGFR) ELISA Kit

RDR-EGFR-Ra-48Tests 48 Tests
EUR 470

Rat Epidermal Growth Factor Receptor (EGFR) ELISA Kit

RDR-EGFR-Ra-96Tests 96 Tests
EUR 651

Human Epidermal Growth Factor Receptor (EGFR) ELISA Kit

RD-EGFR-Hu-48Tests 48 Tests
EUR 418

Human Epidermal Growth Factor Receptor (EGFR) ELISA Kit

RD-EGFR-Hu-96Tests 96 Tests
EUR 575

Mouse Epidermal Growth Factor Receptor (EGFR) ELISA Kit

RD-EGFR-Mu-48Tests 48 Tests
EUR 429

Mouse Epidermal Growth Factor Receptor (EGFR) ELISA Kit

RD-EGFR-Mu-96Tests 96 Tests
EUR 591

Rat Epidermal Growth Factor Receptor (EGFR) ELISA Kit

RD-EGFR-Ra-48Tests 48 Tests
EUR 450

Rat Epidermal Growth Factor Receptor (EGFR) ELISA Kit

RD-EGFR-Ra-96Tests 96 Tests
EUR 622

Mouse Epidermal Growth Factor Receptor (EGFR/Errb-1/HER1) ELISA Kit, 96 tests, quantitative

210-130-EGFR 1 Kit
EUR 773

Turbo Prime Broth™

120 500 ml
EUR 64

TAS-120

B2354-25
EUR 756

TAS-120

B2354-5
EUR 229

YE 120

B5603-10 10 mg
EUR 373

YE 120

B5603-50 50 mg
EUR 1363

AG-120

B7805-25 25 mg
EUR 437
Description: IC50: < 100 nMAG-120 is an IDH1 inhibitor.Isocitrate dehydrogenase (IDH) is a metabolic enzyme interconverting isocitrate and ?-ketoglutarate (?-KG), but cancer-associated mutations of IDH1 and IDH2 confer a neomorphic activity, which allows reduction of ?-KG to the oncometabolite 2-HG.

AG-120

B7805-5 5 mg
EUR 168
Description: IC50: < 100 nMAG-120 is an IDH1 inhibitor.Isocitrate dehydrogenase (IDH) is a metabolic enzyme interconverting isocitrate and ?-ketoglutarate (?-KG), but cancer-associated mutations of IDH1 and IDH2 confer a neomorphic activity, which allows reduction of ?-KG to the oncometabolite 2-HG.